Genetic Testing for Psychiatric Disorders: Is It Ready for Primetime? Focus on Neurology and Psychiatry

    • Science

Host: Mimi Secor, DNP, FNP-BC, FAANP

Guest: James B, Potash, MD, MPH


Psychopharmacology is the study of genetic variations to pinpoint more effective personalized treatments for psychiatric disorders. But with clinicians, industry heads, insurance providers, and regulating agencies all weighing in on this practice and forming varying opinions, what’s the best way to move forward? Here to answer that question and others with Dr. Mimi Secor is Dr. James Potash, a Professor of Psychiatry and Behavioral Sciences and Psychiatrist in Chief at the John Hopkins Department of Psychiatry.

Host: Mimi Secor, DNP, FNP-BC, FAANP

Guest: James B, Potash, MD, MPH


Psychopharmacology is the study of genetic variations to pinpoint more effective personalized treatments for psychiatric disorders. But with clinicians, industry heads, insurance providers, and regulating agencies all weighing in on this practice and forming varying opinions, what’s the best way to move forward? Here to answer that question and others with Dr. Mimi Secor is Dr. James Potash, a Professor of Psychiatry and Behavioral Sciences and Psychiatrist in Chief at the John Hopkins Department of Psychiatry.

Top Podcasts In Science

More by ReachMD